Small molecule share of Phase I trial starts
Share of Phase I clinical trial starts that examine small molecule drugs.
Unit Percent Industry Healthcare
The chart
Over time
Global over time. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.
Every record
All records
6 records · 1 region · 2016–2025
| Period | Value | Source | Type |
|---|---|---|---|
| Global 6 records | |||
| 2025 | 62% | IQVIA · 31 Dec 2025 | actual |
| 2025 | 62% | IQVIA · 31 Dec 2025 | actual |
| 2023 | 60% | IQVIA · 31 Dec 2023 | actual |
| 2023 | 60% | IQVIA · 31 Dec 2023 | actual |
| 2016 | 72% | IQVIA · 31 Dec 2016 | actual |
| 2016 | 72% | IQVIA · 31 Dec 2016 | actual |
Primary documents
Sources
2 documents. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Global R&D Trends 2026 | IQVIA | — | 3 |
| Global R&D Trends 2026 | IQVIA | — | 3 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Small molecule share of Phase I trial starts. Retrieved from https://statorigin.org/indicators/small-molecule-share-of-phase-i-trial-starts